MedTrace Logo

Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis

NCT02964000 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2017-02-23

No results posted yet for this study

Summary

Hypothesis: Use of high level vs low level cold laser treatments will reduce chronic pain and the need for PRN opioid-containing analgesic medications.

Secondary Hypothesis: High level (vs low level) laser treatments will increase the patients level of physical activity and quality of sleep.

Conditions

Interventions

DEVICE

Low level 1 Watt

The Phoenix Thera-Lase System will be on 1 watt

DEVICE

Phoenix Thera-Lase System 42

The Phoenix Thera-Lase System will be on 42 watts

DEVICE

Phoenix Thera-Lase System 74

The Phoenix Thera-Lase System will be on 74 watts

Sponsors & Collaborators

  • Phoenix Thera-lase Systems, LLC

    lead INDUSTRY

Principal Investigators

  • Paul F White, PhD, MD · Phoenix Thera-Lase Systems

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02964000 on ClinicalTrials.gov